financetom
Business
financetom
/
Business
/
Ovintiv Renews Normal Course Issuer Bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ovintiv Renews Normal Course Issuer Bid
Sep 29, 2025 2:40 PM

05:17 PM EDT, 09/29/2025 (MT Newswires) -- Ovintiv ( OVV ) said late Monday it secured regulatory approvals from the Toronto Stock Exchange to renew its normal course issuer bid to buy back almost 22.3 million common shares over the 12-month period starting Oct. 3.

The company also renewed its automatic share purchase plan to buy shares under the issuer bid when it would not be allowed to purchase shares due to regulatory limits and blackout periods, according to the company.

Ovintiv ( OVV ) repurchased over 7.8 million common shares at an average price of $38.8 apiece out of the 25.9 million under its existing issuer bid, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Sonida Senior Living Is In Advanced Talks To Acquire CNL Healthcare Properties For $1.8 Billion-WSJ
BRIEF-Sonida Senior Living Is In Advanced Talks To Acquire CNL Healthcare Properties For $1.8 Billion-WSJ
Nov 4, 2025
Nov 4 (Reuters) - * SONIDA SENIOR LIVING IS IN ADVANCED TALKS TO ACQUIRE CNL HEALTHCARE PROPERTIES FOR $1.8 BILLION-WSJ Source text: https://tinyurl.com/ycxau4xa Further company coverage: ...
Amgen profit beats estimates, weight-loss data due by year-end
Amgen profit beats estimates, weight-loss data due by year-end
Nov 4, 2025
(Reuters) -Amgen ( AMGN ) on Tuesday reported quarterly financial results that beat Wall Street expectations as product sales rose 12%, offsetting higher operating expenses related to experimental weight-loss drug MariTide and a higher tax rate. The California-based biotech company's third-quarter revenue also rose 12% from a year earlier to $9.56 billion. Adjusted earnings per share increased 1% to $5.64....
Rivian tops revenue expectations as buyers rush before EV incentive expiry
Rivian tops revenue expectations as buyers rush before EV incentive expiry
Nov 4, 2025
(Reuters) -Rivian Automotive ( RIVN ) surpassed Wall Street expectations for third-quarter revenue on Tuesday, fueled by strong deliveries as U.S. consumers rushed to grab a federal tax incentive on electric vehicle purchases before its expiry. Shares of the Irvine, California-based company rose more than 3% in trading after the bell. The company said last month it delivered 13,201 vehicles...
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2025
MONTREAL and CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. ( MIST ) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 65,000 options (the “Options”) to purchase the Company’s common shares, pursuant to the Company’s 2021 Inducement Plan (the “Plan”), previously approved by the Company’s Compensation...
Copyright 2023-2026 - www.financetom.com All Rights Reserved